Results 201 to 210 of about 44,272,182 (308)

Blood RNA Biomarker Signatures for Early Diagnosis and Prognosis in Ischemic and Hemorrhagic Stroke: The IBIS‐CT1 Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the expression of nine blood RNA biomarkers in a clinical trial based on genes previously identified in an experimental monkey model of stroke for diagnosis feasibility and prognostication. Methods IBIS‐CT1 was a prospective longitudinal study enrolling patients with ischemic stroke (IS) or intracerebral hemorrhage (ICH ...
Salomé Retailleau, Marie Bruguet, Irina Viakhireva‐Dovganyuk, François‐Mathias Merrien, Denis Marechal, Aurore Jourdain, Philippe Goas, Jordan Coris, Julien Asselineau, Maëlys Consigny, Gérald Le Gac, Serge Timsit   +11 more
wiley   +1 more source

Author Correction: Surveillance of avian influenza through bird guano in remote regions of the global south to uncover transmission dynamics. [PDF]

Nat Commun
Wannigama DL, Amarasiri M, Phattharapornjaroen P, Hurst C, Modchang C, Besa JJV, Miyanaga K, Cui L, Fernandez S, Huang AT, Ounjai P, Werawatte WKCP, Rad S M AH, Vatanaprasan P, Jay DJ, Saethang T, Luk-In S, Kanthawee P, Thuptimdang W, Tacharoenmuang R, Cynthia B, Vitharana SPHS, Ngamwongsatit N, Ishikawa H, Furukawa T, Wang Y, Singer AC, Ragupathi NKD, Chatsuwan T, Sei K, Nanbo A, Leelahavanichkul A, Kanjanabuch T, Hamamoto H, Higgins PG, Sano D, Kicic A, Valdebenito JO, Bonnedahl J, Trowsdale S, Hongsing P, Khatib A, Shibuya K, Abe S.   +43 more
europepmc   +1 more source

Modeling Progressive Brain Volume Losses in Chronic Moderate Severe Traumatic Brain Injury: Extensive, but Attenuating

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Progressive brain atrophy has now been widely observed in the chronic stages of moderate–severe traumatic brain injury (msTBI), but there is only coarse information regarding its prevalence and magnitude, and whether rate of atrophy accelerates or attenuates across time. We examined these questions in a Canadian inception cohort from
Robin E. A. Green, Brenda Colella, Alana Changoor, David J. Mikulis, Adrienne Li, Kadeen Johns, Georges A. Monette   +6 more
wiley   +1 more source

Ten simple rules for effective use of generative AI for code development in environmental science

PLOS Computational Biology
Rachel A. King, Laurel Abowd, Carlo W. Broderick, LM Bradley, Max F. Czapanskiy, Mona M. Farnisa, Erica M. Ferrer, Carmen Galaz García, Darian Gill, Nicole M. Greco, Juliette Jacquemont, Justin A. Kadi, Li Kui, Gretchen LeBuhn, Liying Li, Abigail Meyer, Marisa Morse, Evan Patrick, Samantha Shanny-Csik, Nicholas A. C. Tucker, Zhe Wang, Caitlin R. Fong   +21 more
openaire   +3 more sources

The Comprehensive Live Cell‐Based Cytotoxicity Assay for Monitoring Disease Activity and Guiding Rescue Therapy in Acute Attacks of NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a devastating neurological disease that lacks serological biomarkers that can accurately reflect disease activity. We established a live cell‐based assay (LCBA) using serum with endogenous complement to quantify the overall cytotoxicity, offering a novel functional tool for monitoring
Xiaona Xu, Jie Ding, Yupeng Du, Guibao Luo, Jinming Li, Rui Liu, Xiaoyi Xu, Xiao Li, Minshu Li, Wei Jiang, Chunsheng Yang   +10 more
wiley   +1 more source

Teaching computational toxicology as new approach methodologies in the era of next-generation risk assessment. [PDF]

Front Toxicol
Liu S, Li J, Tang D, Shao K, Xue Q, Carmichael PL, Pi J, Zhang Q.   +7 more
europepmc   +1 more source

Autoimmune Comorbidities as Modifiers of Phenotypic Heterogeneity in Facioscapulohumeral Dystrophy

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral dystrophy type 1 (FSHD1) shows clinical heterogeneity that is only partly explained by D4Z4 repeat unit (RU) size. Although immune and inflammatory mechanisms may contribute to disease variability, the prevalence and clinical impact of autoimmune diseases in FSHD remain unclear.
Jonathan Pini, Giulia Tammam, Andra Ezaru, Manuela Gambella, Benoît Sanson, Luisa Villa, Michele Cavalli, Mihai‐Bogdan Ioncea, Angela Puma, Sabrina Sacconi   +9 more
wiley   +1 more source

From Self-Worth to Sustainable Choice: An Efficacy-Translation Account of Green Consumption. [PDF]

Behav Sci (Basel)
Jiang T, Hu F, Yang X, Guo M.
europepmc   +1 more source

Systemic Extracerebral Atherosclerotic Burden and Dementia Risk After Incident Stroke

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Stroke survivors are at increased risk of dementia, but clinically accessible markers of risk heterogeneity remain limited. Previous studies have largely examined atherosclerotic disease in individual vascular beds rather than the overall burden of systemic extracerebral atherosclerosis.
Zhexuan Yu, Tianxue Chen, Wei Jin, Weifeng Jin, Haitong Wan   +4 more
wiley   +1 more source

Planta Centennial editorial. [PDF]

Planta
Bartels D, Cheng MHK, de Folter S.
europepmc   +1 more source